KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $66.0 million.

  • Chemed's Free Cash Flow fell 1421.67% to $66.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $360.4 million, marking a year-over-year increase of 1530.59%. This contributed to the annual value of $368.0 million for FY2024, which is 3456.67% up from last year.
  • Chemed's Free Cash Flow amounted to $66.0 million in Q3 2025, which was down 1421.67% from $122.8 million recorded in Q2 2025.
  • In the past 5 years, Chemed's Free Cash Flow registered a high of $152.2 million during Q4 2024, and its lowest value of $9.4 million during Q2 2021.
  • Moreover, its 5-year median value for Free Cash Flow was $72.4 million (2024), whereas its average is $71.2 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first tumbled by 9465.6% in 2021, then surged by 36339.11% in 2022.
  • Quarter analysis of 5 years shows Chemed's Free Cash Flow stood at $49.4 million in 2021, then surged by 65.98% to $81.9 million in 2022, then increased by 18.12% to $96.8 million in 2023, then skyrocketed by 57.21% to $152.2 million in 2024, then plummeted by 56.6% to $66.0 million in 2025.
  • Its last three reported values are $66.0 million in Q3 2025, $122.8 million for Q2 2025, and $19.5 million during Q1 2025.